REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced that the National Institute of Health and Care Excellence (NICE) has renewed its support for the use of its AI-powered HeartFlow® FFRct Analysis to fight coronary heart disease (CHD), one of the leading causes of death in the UK. NICE has found that the HeartFlow Analysis continues to improve patient experience and reduce the need for invasive angiography, four years after it